SCHEMBL24170127

SCHEMBL24170127

CC(CN1C(=O)c2ccccc2C1=O)c1ccc2ncccc2c1

nearest known ligand 0.44

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ POLB P06746 2/20 0.44
▸ PSMD14 O00487 1/20 0.44
▸ TP53 P04637 1/20 0.44
▸ MMP2 P08253 1/20 0.44
▸ MET P08581 8/20 0.44
▸ CYP1B1 Q16678 1/20 0.43
▸ ALDH1A1 P00352 5/20 0.41
▸ LMNA P02545 2/20 0.41
▸ SMN1; SMN2 Q16637 2/20 0.41
▸ AKR1C3 P42330 1/20 0.41
▸ AKR1C2 P52895 1/20 0.41
▸ NR3C1 P04150 1/20 0.40
▸ IDH1 O75874 1/20 0.40
▸ MEN1 O00255 1/20 0.40
▸ PKM P14618 1/20 0.40
▸ KMT2A Q03164 1/20 0.40
▸ NPC1 O15118 1/20 0.39
▸ RAB9A P51151 1/20 0.39
▸ MAPK1 P28482 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20309118 0.76 ALDH1A1 (0.53) POLBTP53METALDH1A1LMNA
SCHEMBL29473917 0.76 ALDH1A1 (0.53) POLBTP53METALDH1A1LMNA
SCHEMBL114725 0.76 ALDH1A1 (0.53) POLBTP53METALDH1A1LMNA
Methane SCHEMBL28862287 0.75 ALDH1A1 (0.51) POLBTP53METALDH1A1LMNA
SCHEMBL1163336 0.75 CYP1B1 (0.69) POLBPSMD14TP53MMP2MET
SCHEMBL5778369 0.74 ALDH1A1 (0.47) POLBTP53METALDH1A1LMNA
SCHEMBL12182699 0.73 ALDH1A1 (0.44) POLBALDH1A1SMN1; SMN2MEN1PKM
SCHEMBL14928667 0.73 HTT (0.46) TP53ALDH1A1SMN1; SMN2PKMKMT2A
Bicarbonate SCHEMBL28288596 0.73 ALDH1A1 (0.59) POLBMETALDH1A1LMNASMN1; SMN2
SCHEMBL1954298 0.73 MET (0.49) POLBTP53METALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022000443-A1 METHODS AND COMPOSITIONS FOR TARGETING TREGS USING CCR8 INHIBITORS Nanjing Immunophage Biotech Co., Ltd. (CN) 2022-01-06 — — WO disclosed
Send feedback